Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase

PUBT · 2d ago
Hanx Biopharmaceuticals files HKEX next-day disclosure return on share repurchase
  • Hanx Biopharmaceuticals repurchased 45,700 H shares on July 13, 2026 for treasury; no shares were repurchased for cancellation.
  • Buyback price range HKD 28.48 to HKD 30; aggregate consideration HKD 1.32 million.
  • Issued shares excluding treasury fell to 134,250,730; treasury shares rose to 1,968,100.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals (Wuhan) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260713-12242762), on July 13, 2026, and is solely responsible for the information contained therein.